KERATITNI DAVOLASHNING ZAMONAVIY YONDASHUVLARI

Hamroyev Behzod Gulmurotovich; Najmiddinov Husen Najmiddinovich

Authors

Hamroyev Behzod Gulmurotovich Tayanch doktorant: Buxoro davlat tibbiyot institute
Najmiddinov Husen Najmiddinovich RIKMIATM Buxoro filiali oftalmologi

Keywords:

keratit, zamonaviy davolash, regenerativ tibbiyot, trombotsitga boy plazma, antibiotik rezistentligi, klinik samaradorlik.

Abstract

Ushbu maqolada keratitni davolashning zamonaviy yondashuvlari tahlil qilingan. Tadqiqotda adabiyotlar tahlili, klinik ma'lumotlar taqqoslash va zamonaviy davolash usullarining samaradorligini baholash usullari qo'llanilgan. Natijalar shuni ko'rsatdiki, regenerativ tibbiyot usullari, xususan trombotsitga boy plazma (TBP), an'anaviy antibiotik terapiyasiga nisbatan yuqori samaradorlikka ega. Maqolada zamonaviy yondashuvlarning afzalliklari va cheklovlari tahlil qilinib, amaliy tavsiyalar berilgan.

Downloads

Download data is not yet available.

References

1. Stapleton F. The epidemiology of infectious keratitis. Ocul Surf. 2023;27:109-16.

2. World Health Organization. Blindness and vision impairment. Fact sheet. August 10, 2023.

3. Efron N, Woods CA, Morgan PB. Quarter of a century of contact lens prescribing trends in Australia (2000–2024). Clin Exp Optom. 2025;108(1):12-18.

4. Antimicrobial Resistance in Ocular Infections: Current Trends and Future Perspectives. Eye. 2024;38(8):1456-1465.

5. Corneal Toxicity of Topical Antimicrobial Agents: A Systematic Review. Cornea. 2023;42(9):1123-1132.

6. The role of platelet-rich plasma in biomedicine. iScience. 2024;27(2):108765.

7. Platelet-derived growth factor concentrations in platelet-rich plasma: A systematic review. Regen Med. 2023;18(7):567-578.

8. The effect of platelet-rich plasma and sodium alginate hydrogel on corneal wound healing. Exp Eye Res. 2024;245:109653.

9. CRISPR/Cas9 gene editing for inherited corneal diseases. Nat Biotechnol. 2024;42(5):678-689.

10. Kang MJ, Lee JH, Hwang J, Chung SH. Efficacy and safety of platelet-rich plasma and autologous-serum eye drops for dry eye in primary Sjögren's syndrome: a randomized trial. Sci Rep. 2023;13:19279.

11. Treatment Duration and Outcomes in Infectious Keratitis: A Multicenter Study. Br J Ophthalmol. 2024;108(3):345-351.

12. Stem cell therapy for severe corneal diseases: Clinical outcomes. Cell Stem Cell. 2024;31(4):456-467.

13. Artificial Intelligence in Ophthalmology: Applications in Corneal Disease Management. Curr Opin Ophthalmol. 2024;35(4):287-294.